Literature DB >> 2633346

Chemotherapeutic malaria control operation by single dose of Fansidar plus primaquine in North Sumatra, Indonesia.

H Doi1, A Kaneko, W Panjaitan, A Ishii.   

Abstract

Selective age group treatment and village scale chemotherapeutic malaria control operation were carried out in east-coast villages in North Sumatra, Indonesia in 1987/1988. A single dose of Fansidar plus primaquine was adopted as the drug regimen to cut the transmission of malaria at the gametocyte stage. After the treatment on day seven, the gametocyte positive rate was reduced to only 2.7% in 72 Plasmodium falciparum gametocyte carriers. A significant reduction of P. falciparum prevalence in the community was observed after successive selective age group treatment in primary school, however P. vivax prevalence persisted. Village scale active case detection was carried out by one health center staff and two village health volunteers. After eight months P. falciparum prevalence was reduced from 14% to 1%. As the result of the chemotherapeutic control activities covering high-prevalence villages in the coastal area, malaria prevalence in 1988 became very low, as compared with the status in 1985/1986.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2633346

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  10 in total

1.  Pharmacokinetics of mefloquine in the presence of primaquine.

Authors:  J Karbwang; K Na Bangchang; A Thanavibul; D J Back; D Bunnag
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Mass drug administration for malaria.

Authors:  Eugenie Poirot; Jacek Skarbinski; David Sinclair; S Patrick Kachur; Laurence Slutsker; Jimee Hwang
Journal:  Cochrane Database Syst Rev       Date:  2013-12-09

Review 3.  Malaria distribution, prevalence, drug resistance and control in Indonesia.

Authors:  Iqbal R F Elyazar; Simon I Hay; J Kevin Baird
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

Review 4.  Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.

Authors:  Patricia M Graves; Hellen Gelband; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2015-02-19

5.  Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.

Authors:  Michele D Hastings; Jason D Maguire; Michael J Bangs; Peter A Zimmerman; John C Reeder; J Kevin Baird; Carol Hopkins Sibley
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

6.  Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication.

Authors:  Shoichi Shimizu; Yoshio Osada; Tamotsu Kanazawa; Yoshiya Tanaka; Meiji Arai
Journal:  Malar J       Date:  2010-03-10       Impact factor: 2.979

Review 7.  Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.

Authors:  Patricia M Graves; Hellen Gelband; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2014-06-30

Review 8.  Review of mass drug administration for malaria and its operational challenges.

Authors:  Gretchen Newby; Jimee Hwang; Kadiatou Koita; Ingrid Chen; Brian Greenwood; Lorenz von Seidlein; G Dennis Shanks; Laurence Slutsker; S Patrick Kachur; Jennifer Wegbreit; Matthew M Ippolito; Eugenie Poirot; Roly Gosling
Journal:  Am J Trop Med Hyg       Date:  2015-05-26       Impact factor: 2.345

Review 9.  Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review.

Authors:  Bipin Adhikari; Nicola James; Gretchen Newby; Lorenz von Seidlein; Nicholas J White; Nicholas P J Day; Arjen M Dondorp; Christopher Pell; Phaik Yeong Cheah
Journal:  Malar J       Date:  2016-11-02       Impact factor: 2.979

Review 10.  Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.

Authors:  Patricia M Graves; Leslie Choi; Hellen Gelband; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2018-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.